Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid
Schmidt E, Obe K, Bröcker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000; 136: 174-8.
Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin
Sitaru C, Schmidt E, Petermann S et al. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol 2002; 118: 664-71.
Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber
Lüftl M, Stauber A, Mainka A et al. Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber. Br J Dermatol 2003; 149: 598-605.
Protein A immunoadsorption: A novel and effective adjuvant treatment of severe pemphigus
Schmidt E, Klinker E, Opitz A et al. Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus. Br J Dermatol 2003; 148: 1222-9.
Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: Evaluation of 602 sessions of extracorporeal immunoadsorption
Matic G, Hofmann D, Winkler R et al. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption. Artif Organs 2000; 24: 103-7.
Adsorption profile of commercially available adsorbents: An in vitro evaluation
Ikonomov V, Samtleben W, Schmidt B et al. Adsorption profile of commercially available adsorbents: an in vitro evaluation. Int J Artif Organs 1992; 15: 312-9.
Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins
Herzog S, Schmidt E, Goebeler M et al. Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins. Acta Derm Venereol 2004; 84: 48-52.